Belgium is experiencing a notable increase in colorectal cancer diagnoses among individuals under the age of 40, a trend identified by the Cancer Foundation based on recent data. While colorectal cancer remains the third most common cancer in the country for both men and women, the rise in younger patients is prompting concern among medical professionals.
Since 2004, the number of diagnoses in this age group has been increasing by nearly 3 percent annually, marking the first time this trend has been definitively observed in Belgium. In 2023, 2.6% of new diagnoses were in patients under 40, rising to 7% for those under 50. This contrasts with a general decline in diagnoses among individuals over 50, attributed in part to the national screening program for those aged 50 to 74, which boasts a five-year survival rate of approximately 70.5%.
Researchers emphasize that the increase in younger patients is likely due to a combination of lifestyle and environmental factors, rather than solely genetic predisposition. A key area of investigation centers on the role of the gut microbiome – the community of bacteria residing in the digestive tract. Studies suggest that the composition and diversity of this microbiome significantly influence both the development of tumors and the body’s response to cancer treatment.
The health of the gut microbiome has been demonstrably impacted by increased antibiotic use and shifts in dietary habits towards a more Westernized pattern. A less diverse microbiome can weaken the immune system and compromise the integrity of the intestinal wall, potentially reducing the body’s natural defenses against cancer. Certain gut bacteria produce toxins, such as colibactin, which can cause DNA damage, inflammation, and suppression of the immune response. Recent research indicates a possible link between exposure to these toxins during childhood and the later development of tumors, as the gut lining is more vulnerable and the microbiome is still developing during those formative years.
The rising incidence of colorectal cancer in younger adults is prompting calls for increased awareness and potential adjustments to screening protocols. While the current screening program targets individuals aged 50 and older, the emerging data suggest a necessitate to consider whether earlier detection efforts are warranted. Although, experts acknowledge that a consensus on widespread screening for younger populations has not yet been reached, and further research is needed to determine the most effective approach.
Recent high-profile cases, including the death of Hollywood actor James Van de Beeck at age 48 from colorectal cancer and the diagnosis of a prominent lawyer, have too contributed to heightened public awareness and encouraged individuals to proactively seek screening.
